Search Results

In vitro small molecule screening to inform novel candidates for use in fluconazole combination therapy in vivo against Coccidioides.

• Authors : Mead, Heather; Valentine, Michael; Yin, Holly

Subjects: Coccidioides; Valley Fever; adjunctive agent

• Source: Microbiology Spectrum. 12(10)

Record details

Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.

• Authors : Becker, Christian; Johnson, Neil; As-Sanie, Sawsan

Subjects: dysmenorrhea; dyspareunia; endometriosis

• Source: Human Reproduction. 39(3)

Record details

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.

• Authors : Liu, Joyce; Gaillard, Stéphanie; Wahner Hendrickson, Andrea

Subjects: Humans; Female; Middle Aged

Record details

Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe

• Authors : Desideri, Giovambattista; Cipelli, Riccardo; Pegoraro, Valeria

Subjects: adherence; amlodipine; antihypertensive drugs

• Source: Current Medical Research and Opinion. 40:733-743

Record details

Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension

• Authors : Tilmann Kramer; Phillip Nattmann; Felix Gerhardt

Subjects: Male; Adult; Endothelin Receptor Antagonists

• Source: ESC Heart FailESC Heart Failure, Vol 11, Iss 3, Pp 1540-1552 (2024)

Record details

Novel combination therapy using recombinant oncolytic adenovirus silk hydrogel and PD-L1 inhibitor for bladder cancer treatment

• Authors : Wenqiang Zhang; Jianqiang Zhang; Jingwei Zhang

Subjects: Silk; Programmed death ligand-1 inhibitor; B7-H1 Antigen

• Source: J NanobiotechnologyJournal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-29 (2024)

Record details

Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial

• Authors : Chan Joo Lee; Woong Chol Kang; Sang Hyun Ihm

Subjects: hypertension; Anticholesteremic Agents; dyslipidemia

• Source: J Clin Hypertens (Greenwich)The Journal of Clinical Hypertension, Vol 26, Iss 3, Pp 262-273 (2024)

Record details

Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges

• Authors : Shujing Ren; Yuhang Xu; Xingpeng Dong

Subjects: 0303 health sciences; Multifunctional nanomedicine; Co-delivery

• Source: J NanobiotechnologyJournal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-33 (2024)

Record details

Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma

• Authors : Junjie Zhao; Yanfeng Tang; Xu Hu

Subjects: Fusion partner; Male; Adult

• Source: Mol CancerMolecular Cancer, Vol 23, Iss 1, Pp 1-8 (2024)

Record details

Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance

• Authors : Manshi Yang; Mengying Cui; Yang Sun

Subjects: QH573-671; Biomarker; Review

• Source: Cell Commun SignalCell Communication and Signaling, Vol 22, Iss 1, Pp 1-20 (2024)

Record details